Analytical Data
-
基因名
FOXI1
- Application
-
别名
FOX-I1; FKHL10; FREAC6; Forkhead-related transcription factor 6; Forkhead-related protein FKHL10; Hepatocyte nuclear factor 3 forkhead homolog 3
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q922I5
-
表达区间
Met1~Asp173
-
分子量
25kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FOXI1, a member of the forkhead box (Fox) transcription factor family, plays a crucial role in various biological processes, particularly in the development and function of epithelial tissues, including the thyroid gland and the respiratory system. The importance of FOXI1 in regulating gene expression related to ion transport, epithelial structure, and cell differentiation has made it a significant focus of research in both developmental biology and disease pathology. Abnormalities in FOXI1 expression have been implicated in several disorders, such as thyroid dysgenesis and congenital hearing loss, highlighting its potential as a biomarker or therapeutic target. The investigation of FOXI1 recombinant protein is essential for elucidating its functional mechanisms and interactions with other cellular factors. By producing and characterizing FOXI1 in a recombinant format, researchers aim to better understand its structural properties, binding affinities, and biological activities. This knowledge is pivotal for developing targeted interventions in diseases associated with FOXI1 dysregulation and advancing our understanding of transcriptional control in epithelial biology. Overall, the study of FOXI1 recombinant proteins promises to provide insights into both fundamental biological processes and potential clinical applications in regenerative medicine and molecular therapies.
